Nuclear nano-architecture markers of gastric cardia and upper squamous esophagus detect esophageal cancer "field effect"

Kenneth E. Fasanella, Rajan K. Bista, Kevin Staton, Sumera Rizvi, Shikhar Uttam, Chengquan Zhao, Antonia Sepulveda, Randall E. Brand, Kevin McGrath, Yang Liu

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Background: Barrett's esophagus (BE) affects up to 12 million Americans and confers an increased risk for development of esophageal adenocarcinoma (EAC). EAC is often fatal unless detected early. Given the high prevalence, high cost of surveillance and relatively low risk of most affected individuals, identification of high-risk patients for additional scrutiny, regular surveillance, or ablative therapy is crucial. The exploration of "field effect" by probing uninvolved esophageal mucosa to predict the risk of EAC has the potential as an improved surveillance and prevention strategy. In this study, we evaluate the ability of nuclear nano-architecture markers from normal squamous esophagus and gastric cardia to detect the "field effect" of esophageal dysplasia and EAC, and their response to endoscopic therapy. Methods: Patients with normal esophagus, gastroesophageal reflux, BE and EAC were eligible for enrollment. We performed endoscopic cytology brushings of the gastric cardia, ~1-2 cm below the gastroesophageal junction, and of the normal squamous esophageal mucosa at ~20 cm from the incisors and standard cytology slides were made using Thinprep method. Optical analysis was performed on the cell nuclei of cytologically normal-appearing epithelial cells. Results: The study cohort consisted of 128 patients. The nuclear nano-architecture markers detected the presence of esophageal dysplasia and EAC with statistical significance. The field effect does not exhibit a spatial dependence. These markers reverted toward normal in response to endoscopic therapy. Conclusions: Optical analysis of gastric cardia and upper squamous esophagus represents a potentially viable method to improve risk stratification and ease of surveillance of patients with Barrett's esophagus and to monitor the efficacy of ablative therapy.

Original languageEnglish (US)
Pages (from-to)626-634
Number of pages9
JournalJournal of Cancer
Issue number8
StatePublished - 2013


  • Dysplasia
  • Esophagus
  • Field effect
  • Nanoscale
  • Nuclear architecture

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Nuclear nano-architecture markers of gastric cardia and upper squamous esophagus detect esophageal cancer "field effect"'. Together they form a unique fingerprint.

Cite this